Evidence map›Paper›PMID 32341518›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2020

The transient receptor potential vanilloid 4 (TRPV4) ion channel mediates protease activated receptor 1 (PAR1)-induced vascular hyperpermeability.

Scott Peng, Megan S Grace, Arisbel B Gondin, Jeffri S Retamal, Larissa Dill, William Darby, Nigel W Bunnett, Fe C Abogadie, Simona E Carbone, Tara Tigani and 4 more

Open access · greenAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Endosomal MrGPRX1 signaling sensitizes TRPV1 to enhance itch.Frontiers in molecular neuroscience · 2026
    Article
  3. Review
  4. Endosomal MrGPRX1 signaling sensitizes TRPV1 to enhance itch.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Role of G-protein coupled receptors in cardiovascular diseases.Frontiers in cardiovascular medicine · 2023
    Review
  12. Review
  13. Diversification of PAR signaling through receptor crosstalk.Cellular & molecular biology letters · 2022
    Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Scott Peng *Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia.
Megan S Grace *School of Medical Sciences and Health Innovations Research Institute, RMIT University, Bundoora, VIC, 3083, Australia.
Arisbel B GondinDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia.
Jeffri S RetamalDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia.
Larissa DillSchool of Medical Sciences and Health Innovations Research Institute, RMIT University, Bundoora, VIC, 3083, Australia.
William DarbySchool of Medical Sciences and Health Innovations Research Institute, RMIT University, Bundoora, VIC, 3083, Australia.
Nigel W BunnettDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia.ORCID http://orcid.org/0000-0003-3367-0644
Fe C AbogadieSchool of Medical Sciences and Health Innovations Research Institute, RMIT University, Bundoora, VIC, 3083, Australia.
Simona E CarboneDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia.ORCID http://orcid.org/0000-0002-4350-6357
Tara TiganiDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia.
Thomas P DavisARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash University, Parkville, VIC, 3052, Australia.
Daniel P PooleDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia. Daniel.Poole@monash.edu.
Nicholas A VeldhuisDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia. Nicholas.Veldhuis@monash.edu.ORCID http://orcid.org/0000-0002-8902-9365
Peter McIntyreSchool of Medical Sciences and Health Innovations Research Institute, RMIT University, Bundoora, VIC, 3083, Australia.
Discovery Institute · USHealth Innovations (United States) · USBaker Heart and Diabetes Institute · AUConvergent Science (United States) · USFlorey Institute of Neuroscience and Mental Health · AUThe University of Melbourne · AU

Funding

Endosomal Platforms for Signaling PainR01NS102722 · NINDS · NEW YORK UNIVERSITY · PI NIGEL W BUNNETT, Brian L Schmidt · 2017 to 2026
$3.4M
Trafficking-Dependent Signaling of Pain by Protease-Activated ReceptorsR01DK118971 · NIDDK · NEW YORK UNIVERSITY · PI BUNNETT, NIGEL W, SCHMIDT, BRIAN L · 2018 to 2021
$3.2M
NIDDK NIH HHS R01 DK118971NINDS NIH HHS R01 NS102722
6 · The paper itself

Abstract

Endothelial barrier disruption is a hallmark of tissue injury, edema, and inflammation. Vascular endothelial cells express the G protein-coupled receptor (GPCR) protease acctivated receptor 1 (PAR1) and the ion channel transient receptor potential vanilloid 4 (TRPV4), and these signaling proteins are known to respond to inflammatory conditions and promote edema through remodeling of cell-cell junctions and modulation of endothelial barriers. It has previously been established that signaling initiated by the related protease activated receptor 2 (PAR2) is enhanced by TRPV4 in sensory neurons and that this functional interaction plays a critical role in the development of neurogenic inflammation and nociception. Here, we investigated the PAR1-TRPV4 axis, to determine if TRPV4 plays a similar role in the control of edema mediated by thrombin-induced signaling. Using Evans Blue permeation and retention as an indication of increased vascular permeability in vivo, we showed that TRPV4 contributes to PAR1-induced vascular hyperpermeability in the airways and upper gastrointestinal tract of mice. TRPV4 contributes to sustained PAR1-induced Ca

Indexed as

AnimalsCalciumCapillary PermeabilityEdemaHEK293 CellsHumansHuman Umbilical Vein Endothelial CellsInflammationMice, Inbred C57BLMice, KnockoutReceptor, PAR-1Receptor, PAR-2Receptors, G-Protein-CoupledSignal TransductionTRPV Cation ChannelsCalciumGPR1 protein, mouseReceptor, PAR-1Receptor, PAR-2Receptors, G-Protein-CoupledTrpv4 protein, mouseTRPV Cation Channels

Identifiers

PMID32341518
PMCPMC10080476
OpenAlexW3018456678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.